Full Text View
Tabular View
No Study Results Posted
Related Studies
Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9
This study has been completed.
Study NCT00000274   Information provided by National Institute on Drug Abuse (NIDA)
First Received: September 20, 1999   Last Updated: August 16, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cocaine-Related Disorders
Substance-Related Disorders
Additional conditions recognized in this trial
Disease
More general conditions related to this trial
Disorders of Environmental Origin
Mental Disorders
Pathologic Processes
Interventions listed in this trial
Flupenthixol
Additional drug interventions recognized in this trial
Flupenthixol decanoate
Haloperidol
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Antiemetics
Antipsychotic Agents
Autonomic Agents
Central Nervous System Agents
Central Nervous System Depressants
Dopamine Agents
Dopamine Antagonists
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
National Institute on Drug Abuse (NIDA)
New York State Psychiatric Institute


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services